milind baldi, pgimer, chandigarh, india...participant clinical case discussion milind baldi, pgimer,...
TRANSCRIPT
![Page 1: Milind Baldi, PGIMER, Chandigarh, India...Participant clinical case discussion Milind Baldi, PGIMER, Chandigarh, India NSCLC –Singapore –15 November 2017 ESMO PRECEPTORSHIP PROGRAM](https://reader030.vdocuments.site/reader030/viewer/2022040520/5e792e884857f572b86c8ae6/html5/thumbnails/1.jpg)
ESMO Preceptorship Programme
Participant clinical case discussion
Milind Baldi, PGIMER, Chandigarh, India
NSCLC – Singapore – 15 November 2017
![Page 2: Milind Baldi, PGIMER, Chandigarh, India...Participant clinical case discussion Milind Baldi, PGIMER, Chandigarh, India NSCLC –Singapore –15 November 2017 ESMO PRECEPTORSHIP PROGRAM](https://reader030.vdocuments.site/reader030/viewer/2022040520/5e792e884857f572b86c8ae6/html5/thumbnails/2.jpg)
ESMO PRECEPTORSHIP PROGRAM
Participant clinical case discussion
May 2014: 67/M, Smoking index: 96 (12x8)
Right upper lobe mass
CT scan guided FNA: Adenocarcinoma
PET scan for disease staging RUL mass (4.0
x 4.8 x 5.6 cm), abutting right innominate vein
with loss of fat planes at places, FDG avid 4R
nodes
EBUS TBNA negative for malignancy
IIIA (T4N0M0)
![Page 3: Milind Baldi, PGIMER, Chandigarh, India...Participant clinical case discussion Milind Baldi, PGIMER, Chandigarh, India NSCLC –Singapore –15 November 2017 ESMO PRECEPTORSHIP PROGRAM](https://reader030.vdocuments.site/reader030/viewer/2022040520/5e792e884857f572b86c8ae6/html5/thumbnails/3.jpg)
ESMO PRECEPTORSHIP PROGRAM
Participant clinical case discussion
May 2014
![Page 4: Milind Baldi, PGIMER, Chandigarh, India...Participant clinical case discussion Milind Baldi, PGIMER, Chandigarh, India NSCLC –Singapore –15 November 2017 ESMO PRECEPTORSHIP PROGRAM](https://reader030.vdocuments.site/reader030/viewer/2022040520/5e792e884857f572b86c8ae6/html5/thumbnails/4.jpg)
ESMO PRECEPTORSHIP PROGRAM
Participant clinical case discussion
Nov 2014
![Page 5: Milind Baldi, PGIMER, Chandigarh, India...Participant clinical case discussion Milind Baldi, PGIMER, Chandigarh, India NSCLC –Singapore –15 November 2017 ESMO PRECEPTORSHIP PROGRAM](https://reader030.vdocuments.site/reader030/viewer/2022040520/5e792e884857f572b86c8ae6/html5/thumbnails/5.jpg)
ESMO PRECEPTORSHIP PROGRAM
Participant clinical case discussion
Nov 16
![Page 6: Milind Baldi, PGIMER, Chandigarh, India...Participant clinical case discussion Milind Baldi, PGIMER, Chandigarh, India NSCLC –Singapore –15 November 2017 ESMO PRECEPTORSHIP PROGRAM](https://reader030.vdocuments.site/reader030/viewer/2022040520/5e792e884857f572b86c8ae6/html5/thumbnails/6.jpg)
ESMO PRECEPTORSHIP PROGRAM
Participant clinical case discussion
May 17
![Page 7: Milind Baldi, PGIMER, Chandigarh, India...Participant clinical case discussion Milind Baldi, PGIMER, Chandigarh, India NSCLC –Singapore –15 November 2017 ESMO PRECEPTORSHIP PROGRAM](https://reader030.vdocuments.site/reader030/viewer/2022040520/5e792e884857f572b86c8ae6/html5/thumbnails/7.jpg)
ESMO PRECEPTORSHIP PROGRAM
Thank you
Participant clinical case discussion